A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer

NCT06283121 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer, Metastatic

Interventions

BIOLOGICAL: BioTTT001 intraperitoneal infusion
DRUG: SOX regimen
DRUG: toripalimab

Sponsor

China Medical University, China

Collaborators

[object Object]